Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer

NCT05117723 is registered in ClinicalTrials.gov with St Vincent's Hospital Melbourne as lead sponsor.

NCT NCT05117723
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05117723 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intraductal Papillary Mucinous Neoplasm (IPMN) Database - A Tool to Predict Pancreatic Cancer
Lead sponsor
St Vincent's Hospital Melbourne
Phase
Observational
Overall status
Recruiting
Start date
August 26, 2021
Completion date
July 31, 2031
Enrollment
1,000 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

ipmn, ipmn, pancreatic